SOURCES SOUGHT
A -- Development and Manufacture of Pharmaceutical Dosage Forms for Treatment of Substance Abuse Disorders
- Notice Date
- 2/17/2026 8:21:21 AM
- Notice Type
- Sources Sought
- NAICS
- 541715
— Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Contracting Office
- NATIONAL INSTITUTES OF HEALTH NIDA Bethesda MD 20892 USA
- ZIP Code
- 20892
- Solicitation Number
- 75N98026R00007
- Response Due
- 3/4/2026 6:00:00 AM
- Archive Date
- 03/04/2026
- Point of Contact
- Scott Duernberger, Phone: 3015940670, Joshua T Lazarus, Phone: 3018276923
- E-Mail Address
-
scott.duernberger@nih.gov, josh.lazarus@nih.gov
(scott.duernberger@nih.gov, josh.lazarus@nih.gov)
- Description
- The National Institute on Drug Abuse (NIDA) is soliciting proposals from qualified organizations having the capability to carry out development of formulations, manufacture, quality control tests, stability studies and distribution of pharmaceutical drug products to be used in the medications development program for treating substance use disorders. Development of medications for the treatment of substance use disorders is a major mission of NIDA. Some of the potential treatment drugs currently being investigated are new chemical entities and previously approved drug substances. The Government acquires these drug substances from private industries, Government contractors/grantees, or independent investigators. This contract is to provide the Government a resource for the development and manufacture of pharmaceutical dosage forms for use in preclinical and clinical studies. Pleas see SSN attached.
- Web Link
-
SAM.gov Permalink
(https://sam.gov/workspace/contract/opp/166756f719b04ed18ee847d19ed8502a/view)
- Place of Performance
- Address: USA
- Country: USA
- Country: USA
- Record
- SN07718318-F 20260219/260217230047 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |